Fervenza, Fernando C.

Evaluating sparsentan for the treatment of focal segmental glomerulosclerosis

Expert Opinion on Pharmacotherapy | August 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1080/14656566.2026.2722324 | PMID 42622490